<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteToxicology &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/application-area/toxicology/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>AminoX: Making Better Protein Drugs, Quicker and Cheaper</title>
				<link>https://wyss.stage.a17.io/media-post/aminox-making-better-protein-drugs-quicker-and-cheaper/</link>
        <pubDate>Wed, 10 Jul 2024 13:56:00 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Protein Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=40393</guid>
                                                <content:encoded><![CDATA[<p>A synthetic biology and advanced chemistry platform that efficiently incorporates non&#x2d;standard amino acids by hacking the ubiquitous protein synthesis process. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/aminox-making-better-protein-drugs-quicker-and-cheaper/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/aminox-making-better-protein-drugs-quicker-and-cheaper/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/07/10095538/Video-Thumbnail-AminoX-No-Text.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c4bd9cd62f212831fb0068e8a9918029"/></url>
				</image>
        			</item>

		
			<item>
				<title>AminoX: Making Better Protein Drugs, Quicker and Cheaper</title>
				<link>https://wyss.stage.a17.io/technology/aminox-making-biologics-safer-with-synthetic-biology-and-advanced-chemistry/</link>
        <pubDate>Wed, 01 May 2024 15:40:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Protein Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=37428</guid>
                                                <content:encoded><![CDATA[<p>Protein drugs often offer the most effective way to treat a variety of medical illnesses and conditions. However, many proteins in their naturally occurring forms make poor drugs &ndash; they can cause toxicities that force patients to discontinue treatment, and they often have such short half&#x2d;lives that patients would need to receive a constant infusion of them to see a therapeutic effect. Recently&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/aminox-making-biologics-safer-with-synthetic-biology-and-advanced-chemistry/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/aminox-making-biologics-safer-with-synthetic-biology-and-advanced-chemistry/</link>
          <title>The AminoX team: Michaël Moret, Helena de Puig, and Erkin Kuru (from left to right). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/08/14125735/AminoX-Team-0689-Final.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=2d132dfab4de58e64b9f50ec81868a55"/></url>
				</image>
        			</item>

		
			<item>
				<title>Paper-Based Diagnostics</title>
				<link>https://wyss.stage.a17.io/technology/paper-based-diagnostics/</link>
        <pubDate>Wed, 01 May 2024 00:34:41 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Paper-based Diagnostics]]></category>
		<category><![CDATA[Paper-based Sensors]]></category>
		<category><![CDATA[RNA]]></category>
		<category><![CDATA[Zika]]></category>
				<guid isPermaLink="false">https://wyss.prod.a17.io/technology/paper-based-sensors/</guid>
                                                <content:encoded><![CDATA[<p>With the imminent threat of new pandemics and frequent disease outbreaks exemplified by the recent Ebola and Zika epidemics, there is a growing need for low&#x2d;cost, easily deployable and simple&#x2d;to&#x2d;use diagnostic tools. The Wyss Institute has developed paper&#x2d;based synthetic gene networks as a next generation diagnostic technology for use in global healthcare crises and patient care. This new type of&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/paper-based-diagnostics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/paper-based-diagnostics/</link>
          <title>A black cartridge containing a paper-based diagnostic for detecting the Zika virus is held up by a researcher at Harvard's Wyss Institute. Areas that have turned purple indicate samples infected with Zika, while yellow areas indicate samples that are free of the virus. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/08/08125624/Paper-based-results-002.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=caa2a0698d47a3b11ede1dd28836ae4a"/></url>
				</image>
        			</item>

		
			<item>
				<title>Coming together to engineer new treatments for serious diseases</title>
				<link>https://wyss.stage.a17.io/news/coming-together-to-revolutionize-therapeutics/</link>
        <pubDate>Mon, 23 Oct 2023 17:14:48 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[Protein Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37959</guid>
                            <description>Three researchers from different disciplines and faculty labs joined forces to develop AminoX, a technology that uses non-standard amino acids to improve protein therapies</description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff Immunotherapy is often seen as the next frontier in cancer treatment, offering many benefits over traditional therapies like radiation and chemotherapy. Unfortunately, immunotherapy patients frequently experience painful side effects because antibodies affect healthy tissues along with the tumor. What if these drugs could more accurately target cancer cells&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/coming-together-to-revolutionize-therapeutics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/coming-together-to-revolutionize-therapeutics/</link>
          <title>The AminoX team: Michaël Moret, Helena de Puig, and Erkin Kuru (from left to right). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/08/14125735/AminoX-Team-0689-Final.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=2d132dfab4de58e64b9f50ec81868a55"/></url>
				</image>
        			</item>

		
			<item>
				<title>Adding immunity to human kidney-on-a-chip advances cancer drug testing</title>
				<link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
        <pubDate>Wed, 23 Aug 2023 14:57:37 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Cell Engineering]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=37512</guid>
                            <description>An immune-infiltrated human kidney organoid-on-chip model enables assessment of kidney toxicities to immunotherapeutic T cell bispecific antibody drugs with high resolution</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (Boston) &mdash; A growing repertoire of cell and molecule&#x2d;based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells. An emerging class of such immunotherapeutics, known as T cell bispecific antibodies (TCBs), are of growing importance with several TCBs that the U.S. Food and Drug Administration (FDA)&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/adding-immunity-to-human-kidney-on-a-chip-advances-cancer-drug-testing/</link>
          <title>The team’s study demonstrated in a novel immune-infiltrated human kidney organoid-on-chip model that a T cell bispecific antibody (TCB) targeting an antigen from the Wilms tumor-1 protein (WT1-TCB) specifically recruits immune cells, including cytotoxic T cells (shown in green), to clusters of podocytes (shown in blue), leading to their destruction. The grey staining is derived from dying cells. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2023/08/22163738/Kidney-organoid-on-chip.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d47559348b52211470cb82f9a9d11ed3"/></url>
				</image>
        			</item>

		
			<item>
				<title>Successfully predicting bone marrow failure caused by drugs, radiation, and disease</title>
				<link>https://wyss.stage.a17.io/news/successfully-predicting-bone-marrow-failure-caused-by-drugs-radiation-and-disease/</link>
        <pubDate>Mon, 27 Jan 2020 15:58:50 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Bone]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=23124</guid>
                            <description>Human Bone Marrow Chip replicates both healthy and damaged bone marrow function, facilitates new discoveries</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Your bone marrow produces about 300 billion new blood cells every single day &ndash; roughly equivalent to the number of stars thought to be in the Milky Way. Being so prolific, however, comes with a price: medical interventions that aim to disrupt cell growth and differentiation, such as chemotherapies and radiation, hit the bone marrow extremely hard&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/successfully-predicting-bone-marrow-failure-caused-by-drugs-radiation-and-disease/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/successfully-predicting-bone-marrow-failure-caused-by-drugs-radiation-and-disease/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2020/01/07120735/Bone-Marrow-on-a-Chip-001b-e1580242924750.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d80f599913387e45b818957b06ac2e27"/></url>
				</image>
        			</item>

		
			<item>
				<title>Liver-Chip Identifies Distinct Drug Toxicities in Human, Rat, and Dog Models</title>
				<link>https://wyss.stage.a17.io/news/liver-chip-identifies-distinct-drug-toxicities-in-human-rat-and-dog-models/</link>
        <pubDate>Wed, 06 Nov 2019 18:58:47 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biosafety]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Liver-on-a-Chip]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=22579</guid>
                            <description>Species-specific Liver-Chip could improve success rate of drug candidates in clinical trials</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Among the numerous microengineered Organ&#x2d;on&#x2d;a&#x2d;Chip (Organ Chip) models developed at Harvard&rsquo;s Wyss Institute, the Liver Chip is of special interest to a number of industries because the real&#x2d;time analysis of complex biochemical interactions could greatly enhance the liver toxicity testing that is ubiquitous in the development of drugs, foods&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/liver-chip-identifies-distinct-drug-toxicities-in-human-rat-and-dog-models/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/liver-chip-identifies-distinct-drug-toxicities-in-human-rat-and-dog-models/</link>
          <title>The Liver-Chip contains two channels – one lined with living organ cells and the other lined with living blood vessel cells – that mimic the physiology of whole organs and allow scientists to study differences in how rat, dog, and human livers respond to drug compounds. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2019/11/05104607/Organ-Chip-282A6210.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=412d8b555fc97e1a446ece93281ca9c4"/></url>
				</image>
        			</item>

		
			<item>
				<title>FcMBL: Broad-Spectrum Pathogen Capture for Infectious Disease Diagnosis and Therapy</title>
				<link>https://wyss.stage.a17.io/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/</link>
        <pubDate>Wed, 11 Sep 2019 00:35:45 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Blood]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[FcMBL]]></category>
		<category><![CDATA[Fungi]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Pathogen]]></category>
		<category><![CDATA[Protein Engineering]]></category>
		<category><![CDATA[Virus]]></category>
				<guid isPermaLink="false">https://wyss.prod.a17.io/technology/capture-and-concentration-of-microbial-pathogens-fcmbl/</guid>
                            <description><a href="https://boabiomedical.com/" target="blank">BOA Biomedical</a> is developing the Wyss Institute's FcMBL pathogen-capture technology into products that quickly remove pathogens from the body and enable their rapid identification, giving critically ill patients a higher chance of survival. </description>
                                        <content:encoded><![CDATA[<p>Infectious diseases have plagued humanity for millennia, and the pathogens that infect and sicken humans are constantly evolving. Severe infections can cause sepsis, a life&#x2d;threatening condition in which a patient&rsquo;s immune system overreacts to the infection. The body starts to attack itself, which can lead to tissue damage, organ failure, and death. Sepsis is very common &ndash; one out of every three&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/fcmbl-broad-spectrum-pathogen-capture-for-infectious-diseases/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/08/08120525/Staph-Beads-Gold.light_.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=9aeaddc3a36a160164da784a440804b2"/></url>
				</image>
        			</item>

		
			<item>
				<title>Organ Chips Featured at Barbican Centre in London</title>
				<link>https://wyss.stage.a17.io/news/organ-chips-featured-at-barbican-centre-in-london/</link>
        <pubDate>Thu, 16 May 2019 12:58:43 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=20380</guid>
                            <description>Exhibit explores the evolution of the relationship between humans and technology</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; Today, a new exhibit called AI: More than Human opens at the Barbican Centre in London, and aims to tell the rapidly developing story of artificial intelligence via a survey of today&rsquo;s cutting&#x2d;edge creative and scientific developments that are questioning what it means to be human. Among the projects featured in the exhibit are two human Organ Chips that were&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/organ-chips-featured-at-barbican-centre-in-london/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/organ-chips-featured-at-barbican-centre-in-london/</link>
          <title>Human Organ Chips, like this Lung Chip, are seeded with living human cells of various organ types and faithfully mimic many of the functions of whole human organs, offering the potential to eliminated animal testing and improve the precision of diagnostic tests and disease treatments. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2016/08/27201056/lung-on-a-chip-illuminated-by-natural-light.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=30564465fd0eab55aea01d203dda8b54"/></url>
				</image>
        			</item>

		
			<item>
				<title>Renal reabsorption in living devices</title>
				<link>https://wyss.stage.a17.io/news/renal-reabsorption-in-living-devices/</link>
        <pubDate>Mon, 04 Mar 2019 19:57:05 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Jennifer A. Lewis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=19603</guid>
                            <description>3D bioprinted, vascularized proximal tubules mimic the human kidney’s reabsorption functions</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (CAMBRIDGE, Mass.) &mdash; Every day our kidneys tackle the daunting task of continuously cleaning our blood to prevent waste, salt and excess fluid from building up inside our bodies. To achieve this, the kidneys&rsquo; approximately one million filtration units (glomeruli) first remove both waste products and precious nutrients from the blood stream&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/renal-reabsorption-in-living-devices/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/renal-reabsorption-in-living-devices/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2019/03/01093942/Vascularized-Proximal-Tubule.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=ac489826557da3832c13f539d53a1d06"/></url>
				</image>
        			</item>

			</channel>
</rss>
